Profile data is unavailable for this security.
About the company
Bioventix plc is a United Kingdom-based company specializing in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, such as in automated immunoassays used in blood testing. The antibodies created at the Company are generated in sheep and are of particular benefit where the target is present at low concentration and where conventional monoclonal or polyclonal antibodies have failed to produce a suitable reagent. It offers a portfolio of antibodies to customers for both commercial use and research and development purposes, for the diagnosis or monitoring of a broad range of conditions, including heart disease, cancer, fertility, thyroid function, and drug abuse. The Company’s products include sheep monoclonal antibodies (SMAs), Pyrene (HOP-G) ELISA Kits, and Pyrene (HOP-G) Lateral Flow Kits. The Company supplies antibody products and services to the majority of multinational clinical diagnostics companies.
- Revenue in GBP (TTM)13.60m
- Net income in GBP8.67m
- Incorporated2003
- Employees16.00
- LocationBioventix PLC7 Romans Business Park, East StreetFARNHAM GU9 7SXUnited KingdomGBR
- Phone+44 12 5272 8001Fax+44 12 5272 8002
- Websitehttps://www.bioventix.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Poolbeg Pharma PLC | 0.00 | -4.38m |
Futura Medical PLC | 8.40m | -3.75m |
Scancell Holdings Plc | 0.00 | -5.86m |
4Basebio PLC | 596.00k | -9.84m |
Avacta Group Plc | 22.62m | -25.89m |
hVIVO PLC | 64.38m | 17.45m |
Bioventix PLC | 13.60m | 8.67m |
Allergy Therapeutics plc | 53.26m | -50.22m |
Faron Pharmaceuticals Oy | 0.00 | -26.45m |
Puretech Health PLC | 356.82k | -62.87m |
Oxford BioMedica plc | 97.28m | -142.02m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Sanford DeLand Asset Management Ltd.as of 10 Apr 2024 | 619.50k | 11.87% |
Liontrust Investment Partners LLPas of 27 Oct 2023 | 574.16k | 11.00% |
Link Fund Solutions Ltd.as of 30 Apr 2024 | 363.63k | 6.97% |
Gresham House Asset Management Ltd. (Investment Management)as of 01 Sep 2023 | 289.00k | 5.54% |
Rathbones Investment Management Ltd.as of 27 Oct 2023 | 164.94k | 3.16% |
Investec Wealth & Investment Ltd.as of 01 Sep 2023 | 145.00k | 2.78% |
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 May 2023 | 125.79k | 2.41% |
Hargreaves Lansdown Asset Management Ltd.as of 01 Sep 2023 | 114.00k | 2.18% |
EdenTree Investment Management Ltd.as of 01 Sep 2023 | 100.00k | 1.92% |
Walker Crips Investment Management Ltd.as of 01 Sep 2023 | 70.00k | 1.34% |